- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about SNY
Recent news which mentions SNY
'Transformative Event' For First Wave BioPharma: License Agreement for Hopeful Gastrointestinal Candidate From Sanofi
September 14, 2023
From Benzinga
Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm
September 13, 2023
From InvestorPlace
Could This Medicine Be the Next Winner for Novartis?
August 23, 2023
From Motley Fool
From Benzinga
Pfizer maternal RSV vaccine gets FDA approval
August 21, 2023
From MarketWatch
Is Regeneron Pharmaceuticals Still a Top Growth Stock?
August 21, 2023
From Motley Fool
2 Biotech Stocks That Could Make You Richer
August 18, 2023
From Motley Fool
From Benzinga
2 Top Biotech Stocks to Buy Right Now
August 14, 2023
From Motley Fool
Why Shares of MacroGenics Are Jumping Thursday
August 10, 2023
From Motley Fool
As Tiziana Life Sciences (NASDAQ: TLSA) Prepares For Phase 2 Trials, Have They Successfully Derisked Foralumab?
August 08, 2023
From Benzinga
Tiziana (NASDAQ: TLSA) Continues The Fight Against Multiple Sclerosis, Will Announce 6-Month Results For Its Novel Treatment Soon
August 03, 2023
From Benzinga
The Top Healthcare Stocks to Buy With $100
July 30, 2023
From Motley Fool
From Benzinga
US Stock Futures Signal Rebound On Tech Earnings Support: Analyst Tells Why Fed May Not Start Cutting Rates Anytime Soon
July 28, 2023
From Benzinga
Enphase Energy, Sanofi, Ford And Other Big Stocks Moving Lower In Friday's Pre-Market Session
July 28, 2023
From Benzinga
Earnings Scheduled For July 28, 2023
July 28, 2023
From Benzinga
Novo Nordisk's Diabetes, Weight Loss Drugs Under UK Scrutiny: Follows Suicidal Behavior Reports
July 26, 2023
From Benzinga
From InvestorPlace
From Benzinga
AstraZeneca-Sanofi's Respiratory Syncytial Virus Treatment Scores FDA Approval To Prevent Infection In Infants
July 18, 2023
From Benzinga
From Benzinga
Is Affordable Insulin Available? Survey Reveals Uninsured Americans Paying More Despite Promised Price Reduction
July 13, 2023
From Benzinga
Why Shares of Exscientia Jumped on Wednesday
July 12, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.